Skip to content

Seminar Title

 

Synergy Satellite: Targeted drugs – scattered goals (sponsored by a grant from Novartis)

Affiliation

German Cancer Research Center & University Hospital Heidelberg

Country

Germany

1. Current Status, Position

  • Head of Division, CCU Pediatric Oncology, DKFZ Heidelberg;
  • Head of Division, Pediatric Brain Tumors, University Hospital Heidelberg.

2. Education

  • Training in Pediatrics, Pediatric Oncology and Neonatal Medicine at University of Göttingen Medical School;
  • Postdoctoral Fellow in Molecular Biology of Histone Family Variants in Cancer at University of Göttingen;
  • W3 joined professorship at DKFZ/University Hospital Heidelberg and Head of Division CCU Pediatric Oncology since 2005.

3. Research Area

  • Clinical Specialization in Pediatric Neurooncology;
  • Interest in Personalized Pediatric Oncology, novel targeted treatment approaches, clinical translation of novel targets based on mechanism of action;
  • Evaluation of individual members of histone deacetylase family as selective drug targets and their mechanism of action.

Conflict of interest: Consultant for Astra Zeneca and Novartis and Research Grant Recipient from Bayer Healthcare.